It has been reported that ELOVL4 serves as a tumor suppressor via the NOTCH-RIPK4-IRF6-ELOVL4 axis in squamous cell carcinoma, and its overexpression is related to the good prognosis for neuroblastoma patients [33, 34]. Here, RIPK4 is linked to neuroblastoma.